Plan for Systematic Identification of Lung Cancers of Occupational Origin: Implementation Study
NCT ID: NCT02696863
Last Updated: 2017-09-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
20 participants
OBSERVATIONAL
2016-03-31
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The secondary objective is to assess patient knowledge and information received on their previous occupational exposure during their professional activity.
This is a prospective multicenter study of qualitative methodology through in-depth interviews conducted with patients treated at ICLN and CHU Saint-Etienne
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung Cancer Nurse Model: a Phase II Study
NCT02362204
Determinants of Intensity of Care of Lung Cancer Patients With Organ Failure
NCT01999621
Breath Analysis to Diagnose Lung Cancer
NCT03250390
Lung Cancer Screening in a Population Exposed to Occupational Lung Carcinogens
NCT03562052
Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer
NCT01956331
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
filling a questionnaire and interview
The questionnaire is tracking occupational carcinogens. It consists of 30 questions , fills an average of 3 minutes and includes three response categories: "yes", "no" and "do not know". A questionnaire will be added social and professional issues.
Interviews will be conducted with the patient to identify obstacles and facilitating elements
questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients employees or have been employees of the general scheme and / or the agricultural social security system;
* Patients understand French.
Exclusion Criteria
* recognized disability in patients for CBP by the social security system;
* Patients who have never been employees of the General or the agricultural social security system plan
* Patients already included in phase 1 of the study;
* Refusal of participation, signed consent major patients protected under guardianship;
* Patients unable to understand the course of the study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Institut de Cancérologie de la Loire
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Saint-Etienne
Saint-Etienne, , France
ICLN
Saint-Priest-en-Jarez, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-05
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.